Search clinical trials for: ibrutinib and Tisagenlecleucel
Total 271546 results
-
Pharmacyclics LLC.CompletedFollicular Lymphoma | B-cell Lymphoma | Non-Hodgkin's LymphomaUnited States
-
M.D. Anderson Cancer CenterJanssen Scientific Affairs, LLCWithdrawnLung Cancer, Nonsmall Cell, Stage I
-
Cancer Institute and Hospital, Chinese Academy...Not yet recruitingRefractory Lymphoma | DLBCL | MYD88 Gene Mutation | Relapse | CD79A Gene Mutation | CD79B Gene Mutation
-
Lixia ShengNot yet recruitingOR Regimen Refractory Marginal Zone Lymphoma
-
Dana-Farber Cancer InstituteAcetylon Pharmaceuticals IncorporatedActive, not recruitingRecurrent Chronic Lymphoid LeukemiaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingRecurrent Small Lymphocytic Lymphoma | Refractory Chronic Lymphocytic Leukemia | Recurrent Chronic Lymphocytic Leukemia | Refractory Small Lymphocytic Lymphoma | Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaUnited States
-
Janssen Cilag S.A.S.RecruitingLeukemia, Lymphocytic, Chronic, B-CellFrance
-
Janssen Research & Development, LLCActive, not recruitingLymphoma, Non-Hodgkin | Leukemia, Lymphocytic, Chronic, B-CellDenmark, France, Poland, Sweden
-
Kerry RogersJanssen Research & Development, LLCWithdrawnChronic Lymphocytic Leukemia | Loss of Chromosome 17p
-
National Heart, Lung, and Blood Institute (NHLBI)Active, not recruitingLeukemia, Lymphocytic, Chronic, B-Cell | Chronic Lymphocytic Leukemia | Leukemia, Chronic Lymphatic | B-Cell Chronic Lymphocytic Leukemia | Leukemia, Lymphocytic, Chronic | B-Lymphocytic Leukemia, Chronic | Leukemia, Chronic Lymphocytic, B-Cell | Lymphocytic Leukemia, Chronic, B Cell | Lymphocytic Leukemia...United States
-
Acerta Pharma BVActive, not recruitingChronic Lymphocytic LeukemiaUnited States, Italy, Spain, United Kingdom, Belgium, Denmark, Hungary, Poland, Australia, Germany, Israel, Netherlands, Turkey, France, New Zealand
-
Swiss Group for Clinical Cancer ResearchActive, not recruitingLeukemia | Chronic Lymphocytic Leukemia | Relapsed/Refractory Chronic Lymphocytic LeukemiaSwitzerland
-
Steven E. CoutreCompletedRecurrent Small Lymphocytic Lymphoma | Refractory Chronic Lymphocytic Leukemia | Recurrent Chronic Lymphocytic Leukemia | Refractory Small Lymphocytic LymphomaUnited States
-
M.D. Anderson Cancer CenterPharmacyclics LLC.Completed
-
German CLL Study GroupHoffmann-La Roche; Janssen-Cilag Ltd.CompletedChronic Lymphocytic LeucemiaGermany
-
Georgetown UniversityNational Cancer Institute (NCI)TerminatedChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
Alliance Foundation Trials, LLC.PfizerActive, not recruitingB Cell Lymphoma | Mantle Cell LymphomaUnited States
-
The Lymphoma Academic Research OrganisationInstitute of Cancer Research, United KingdomRecruitingMantle Cell LymphomaFrance, United Kingdom, Belgium
-
National Cancer Institute (NCI)Active, not recruitingHairy Cell Leukemia | Recurrent Hairy Cell Leukemia | Hairy Cell Leukemia VariantUnited States
-
BeiGeneCompletedChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaPoland
-
Pharmacyclics LLC.CompletedChronic Lymphocytic Leukemia | Small-Cell LymphomaUnited States, Australia, Austria, Belgium, Canada, Czechia, France, Israel, Italy, New Zealand, Poland, Russian Federation, Spain, Sweden, Turkey, United Kingdom
-
Pharmacyclics LLC.Janssen Research & Development, LLCCompletedChronic Graft Versus Host DiseaseUnited States, Australia, Austria, Canada, China, Croatia, France, Germany, Hungary, Italy, Japan, Korea, Republic of, Singapore, Spain, Taiwan
-
Merck Sharp & Dohme LLCRecruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States, Israel, Taiwan, United Kingdom, Chile, Canada, Japan, Brazil, China
-
Janssen Research & Development, LLCPharmacyclics LLC.RecruitingLeukemia, Lymphocytic, Chronic, B-Cell | Small Lymphocytic LymphomaUnited States, Italy, Poland, Spain, Czechia
-
Ohio State University Comprehensive Cancer CenterActive, not recruitingChronic Lymphocytic Leukemia | Ibrutinib ResistanceUnited States
-
Kami MaddocksNational Cancer Institute (NCI)CompletedRecurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Refractory Mantle Cell Lymphoma | Recurrent Burkitt Lymphoma | Recurrent... and other conditionsUnited States
-
Hackensack Meridian HealthJanssen Scientific Affairs, LLC; Genentech, Inc.Active, not recruitingRefractory Diffuse Large B-Cell Lymphoma | Relapsed Diffuse Large B-Cell LymphomaUnited States
-
Eli Lilly and CompanyCompleted
-
Janssen Research & Development, LLCPharmacyclics LLC.CompletedMantle Cell LymphomaFrance, Poland, United Kingdom, Belgium, Germany, Taiwan, Spain, Colombia, Portugal, Ukraine, Canada, Netherlands, Sweden, Korea, Republic of, Chile, Brazil, Russian Federation, Hungary, Ireland, Mexico, Czechia
-
Janssen Research & Development, LLCCompleted
-
Georgetown UniversityAbbVie; Pharmacyclics LLC.; Hackensack Meridian HealthActive, not recruitingRelapsed Follicular Lymphoma | Refractory Follicular LymphomaUnited States
-
National Cancer Institute (NCI)RecruitingLymphoma | Diffuse Large B-Cell Lymphoma | Burkitt Lymphoma | Non-Hodgkin LymphomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMantle Cell LymphomaUnited States
-
Lund University HospitalCelgene; Janssen, LP; Nordic Lymphoma GroupCompletedRelapsed/Refractory Mantle Cell LymphomaFinland, Denmark, Sweden, Norway
-
Cengiz Gokcek Women's and Children's HospitalCompletedPremature Ovarian InsufficiencyTurkey
-
Masonic Cancer Center, University of MinnesotaActive, not recruitingAcute Lymphoblastic Leukemia | Large B-cell LymphomaUnited States
-
Pharmacyclics LLC.Celgene CorporationCompletedDiffuse Large B Cell Lymphoma Refractory | Diffuse Large B Cell Lymphoma RelapsedUnited States
-
AbbVieActive, not recruiting
-
Centre Hospitalier Universitaire de Saint EtienneMinistry of Health, FranceRecruitingPost Menopausal OsteoporosisFrance
-
Institut CurieNational Cancer Institute, FranceRecruitingLymphoma, Large B-Cell, Diffuse | Central Nervous System Neoplasms, PrimaryFrance
-
University of California, DavisPharmacyclics LLC.CompletedMetastatic Renal Cell Cancer | Stage IV Renal Cell CancerUnited States
-
Dana-Farber Cancer InstituteTG Therapeutics, Inc.; The Leukemia and Lymphoma Society; Blood Cancer Research...CompletedMantle Cell Lymphoma | Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Refractory Follicular Lymphoma | Grade 3a Follicular LymphomaUnited States, Canada, Singapore
-
Pharmacyclics LLC.Janssen Research & Development, LLC; Celgene CorporationCompletedRefractory Diffuse Large B-Cell Lymphoma | Relapsed Diffuse Large B-Cell LymphomaUnited States, United Kingdom, Belgium, Germany
-
Ruijin HospitalActive, not recruitingDiffuse Large B Cell LymphomaChina
-
PrECOG, LLC.TakedaCompletedMantle-Cell LymphomaUnited States
-
Brigham and Women's HospitalCompleted
-
University College, LondonJanssen-Cilag Ltd.RecruitingWaldenstrom MacroglobulinemiaUnited Kingdom
-
Hackensack Meridian HealthActive, not recruitingMantle Cell LymphomaUnited States
-
CareFusionCompleted